Terminated NA INTERVENTIONAL 1-arm NCT04832997

Micro-ultrasound for Prostate Cancer Diagnosis

Micro-ultrasound or MRI-targeted Biopsy for Prostate Cancer Diagnosis

Sponsor: IRCCS San Raffaele

Interventions Prostate biopsy systematic random prostate biopsy (TRUS-Bx) + eventual MRI-targeted biopsy (MRI-TBx) + eventual microUS-targeted (Micro-US-TBx)

Updated 5 times since 2021 Last updated: Jul 16, 2025 Started: Sep 14, 2020 Primary completion: Jul 16, 2025 Completion: Jul 16, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

The study faced structural and methodological obstacles, with limited enrollment, technical issues, low adherence, and loss of scientific relevance.

Other terminated trials from IRCCS San Raffaele

See all terminations from IRCCS San Raffaele

Other Prostate Cancer trials with similar outcome

Browse all Prostate Cancer trials

This NA trial investigates Prostate Cancer and is currently terminated or withdrawn. IRCCS San Raffaele leads this study, which shows 5 recorded versions since 2020 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

5 versions recorded

Aug 2025 — Present [monthly]

Terminated NA

Status: Recruiting → Terminated
Sep 2024 — Aug 2025 [monthly]

Recruiting NA
Jul 2024 — Sep 2024 [monthly]

Recruiting NA

Status: Unknown Status → Recruiting
May 2023 — Jul 2024 [monthly]

Unknown Status NA

Status: Recruiting → Unknown Status
May 2021 — May 2023 [monthly]

Recruiting NA

First recorded

Sep 2020

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

IRCCS San Raffaele

Data source: IRCCS San Raffaele

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Milan, Italy